PQ Bypass, a medical device company dedicated to advancing treatment options for patients with peripheral arterial disea...
A research team led by investigators from the National Institutes of Health and Global Good has developed a computer alg...
Amarantus Bioscience Holdings, Inc., a US-based JLABS-alumnus biotechnology holding company developing first-in-class or...
In recent years, an overwhelming body of clinical evidence has firmly established the HIV Undetectable = Untransmittable...
The Janssen Pharmaceutical Companies of Johnson & Johnson has announced the submission of a Group Type II Variation ...
Denali Therapeutics Inc., a biopharmaceutical company developing a broad portfolio of therapeutic candidates for neurode...
Propeller Health, a digital therapeutics company has announced the launch of My Pharmacy feature, connecting Propeller u...
Generex Biotechnology Corporation has announced that the company has entered into a letter of intent (LOI) to acquire Pa...
On the final day of the largest biotechnology and pharmaceutical partnering week at the Juvenescence Longevity Showcase ...
Global combination device testing laboratory, Medical Engineering Technologies (MET), has newly appointed Kevin Claris a...
Embrace by Empatica has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for us...
Volkan Gunduz, PhD, Senior Oncology and Hematology Analyst at GlobalData, a leading data and analytics company, offers h...
Vast Therapeutics, a preclinical stage pharmaceutical company delivering nitric oxide in a powder-based form has announc...
Neosensory, a company that pioneers devices to send information to the brain non-invasively has announced that it has re...
A more comfortable and reliable blood-sugar monitoring system is being designed at KTH Royal Institute of Technology in ...
Aphria Inc. announced that it had completed its previously announced acquisition of CC Pharma GmbH ("CC Pharma...
Medical device company, REVA Medical has announced the geographic expansion of its commercial operations in seven Europe...
Sandoz Inc., a Novartis division, and Pear Therapeutics has announced the US commercial launch of reSET-O(TM) for patien...
